Evolutionary Therapy for Rhabdomyosarcoma
Condition: Rhabdomyosarcoma Interventions: Drug: Vincristine; Drug: Cyclophosphamide; Drug: Vinorelbine; Drug: Actinomycin D; Drug: Cyclophosphamide Pill Sponsors: H. Lee Moffitt Cancer Center and Research Institute; National Pediatric Cancer Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 14, 2020 Category: Research Source Type: clinical trials